Search Results 981-990 of 17400 for Embolism
Stroke, deep vein thrombosis, or pulmonary or arterial embolism within 6 months prior to Screening. Known allergic reaction to any study drug excipient, or ...
This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against ...
Arterial thrombotic or embolic ... Venous thrombotic events (eg, deep vein thrombosis) or pulmonary arterial events (e.g., pulmonary embolism) within the 3 months ...
Have had arterial or venous thrombotic or embolic events such as ... embolism within 6 months prior to the initiation of study treatment. Have a ...
Case report: Allogeneic culture-expanded bone marrow-derived mesenchymal stem cells for the treatment of painful lumbar facet arthropathy ... Low back pain (LBP) ...
In this rare heart defect, the tricuspid heart valve didn't form properly. This can affect the heart's ability to pump blood. Know the risks and symptoms.
Subjects with a history of TEE such as deep vein thrombosis, pulmonary embolism, myocardial infarction, ischemic stroke, transient ischemic attack, peripheral ...
... embolism (PE) or thrombophilia may participate if they are willing to be on full anticoagulation during the treatment if randomized to rituximab ...
Patients with deep vein thrombosis (DVT) or pulmonary embolism (PE) must be on a stable dose of anticoagulation for 14 days prior to registration ...
Pulmonary embolism;; Hemorrhage (CTCAE Grade 3 or 4);; Chronic liver disease (meeting criteria for Child-Pugh Class B or C);; A second active malignancy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.